Article

Caveat emptor NICE: biased use of cost-effectiveness is inefficient and inequitable

2015-10-16

Abstract excerpt

Concern with the threshold applied in cost-effectiveness analyses by bodies such as NICE distracts attention from their biased use of the principle. The bias results from the prior requirement that an intervention be effective (usually 'clinically effective') before its cost-effectiveness is considered. The underlying justification for the use of cost-effectiveness as a criterion, whatever the threshold adopted, i...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: fb7940c2-4dd5-547b-bead-c036280a28f7
DOI: 10.12688/f1000research.7191.1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Caveat emptor NICE: biased use of cost-effectiveness is inefficient and inequitableDOI 10.12688/f1000research.7191.1Read

Economic evaluation in implementation science: A reconciled approach evaluating programmes to increase the uptake of magnesium sulphate in pre-term birthsSemantic proximity Read

Two-year follow-up of a clustered randomised controlled trial of a multicomponent general practice intervention for people at risk of poor health outcomesSemantic proximity Read

Valuing the economic benefits of complex interventions: when maximising health is not sufficient.Semantic proximity Read

Health Technology Assessment of Diagnostic Tests: A state of the art review of methods guidance from international organisationsSemantic proximity Read

Treatment recommendations based on Network Meta-Analysis: rules for risk-averse decision-makersSemantic proximity Read

Methodological Challenges in Dutch HTA of Non-Oncological Orphan Drugs: A Retrospective Analysis and Price Comparison Using different Pricing ModelsSemantic proximity Read

Applying the Non-adoption, Abandonment, Scale-up, Spread and Sustainability (NASSS) Framework to evaluate automated evidence synthesis in health behaviour changeSemantic proximity Read

From impact evaluation to decision-analysis: assessing the extent and quality of evidence on ‘value for money’ in health impact evaluations in low- and middle-income countriesSemantic proximity Read

Issues with Specification of Margins and Analytic Methods on Potential Bias Towards the Alternative in Randomized Noninferiority Pragmatic Trials: Results of a Literature SurveySemantic proximity Read

Smaller clinical trials for decision making; a case study to show p-values are costlySemantic proximity Read

Evidence Synthesis Methods to Estimate Subgroup Effects for Distributional Cost-effectiveness Analysis of New TreatmentsSemantic proximity Read

Demonstrating the value for money of implementing evidence-based treatment: the case for further investment in magnesium sulphate as a neuroprotectant for preterm birthsSemantic proximity Read